Chronological difference in walking impairment among Japanese group A xeroderma pigmentosum (XP-A) patients with various combinations of mutation sites - PubMed (original) (raw)
Case Reports
Chronological difference in walking impairment among Japanese group A xeroderma pigmentosum (XP-A) patients with various combinations of mutation sites
T Maeda et al. Clin Genet. 1995 Nov.
Abstract
Almost all Japanese group A xeroderma pigmentosum (XP-A) patients have nonsense and/or nonsense codon-leading mutations in the XP group A (XPA) gene, and develop neurological abnormalities. Walking ability is one of the most important neuromuscular functions of the patients, because it determines their daily activities. We studied the correlation between the various combinations of mutations found by PCR-RFLP in Japanese XP-A patients and their chronological walking impairment. We classified these patients into six groups. Group I: A patient who was homozygous for the mutation at codon 116 in exon 3 (Type 1 mutation) could never walk unaided. Group III: Typical patients who were homozygous for the mutation at intron 3 (Type 2 mutation) could walk unaided till 7-16 years of age. Group V: Patients who were compound heterozygous for Type 2 mutation and for the mutation at codon 228 in exon 6 (Type 3 mutation) began to develop some walking difficulty at 5-13 years of age and became unable to walk at 25-28 years of age. Group VI: A patient who was homozygous for Type 3 mutation could walk unaided without any difficulty till the age of 21. The walking ability of group II and IV patients is not known yet.
Similar articles
- Three nonsense mutations responsible for group A xeroderma pigmentosum.
Satokata I, Tanaka K, Miura N, Narita M, Mimaki T, Satoh Y, Kondo S, Okada Y. Satokata I, et al. Mutat Res. 1992 Mar;273(2):193-202. doi: 10.1016/0921-8777(92)90080-m. Mutat Res. 1992. PMID: 1372102 - Correlation of the clinical manifestations and gene mutations of Japanese xeroderma pigmentosum group A patients.
Kondoh M, Ueda M, Ichihashi M. Kondoh M, et al. Br J Dermatol. 1995 Oct;133(4):579-85. doi: 10.1111/j.1365-2133.1995.tb02709.x. Br J Dermatol. 1995. PMID: 7577588 - Severe neurological abnormalities associated with a mutation in the zinc-finger domain in a group A xeroderma pigmentosum patient.
Maeda T, Sato K, Minami H, Taguchi H, Yoshikawa K. Maeda T, et al. Br J Dermatol. 1994 Oct;131(4):566-70. doi: 10.1111/j.1365-2133.1994.tb08562.x. Br J Dermatol. 1994. PMID: 7947212 - [Neurological manifestations and molecular basis of group A xeroderma pigmentosum].
Mimaki T, Tanaka K, Nagai A, Mino M. Mimaki T, et al. Nihon Rinsho. 1993 Sep;51(9):2488-93. Nihon Rinsho. 1993. PMID: 8105118 Review. Japanese. - Xeroderma pigmentosum complementation group F: Report of a case and review of Japanese patients.
Tofuku Y, Nobeyama Y, Kamide R, Moriwaki S, Nakagawa H. Tofuku Y, et al. J Dermatol. 2015 Sep;42(9):897-9. doi: 10.1111/1346-8138.12942. Epub 2015 May 25. J Dermatol. 2015. PMID: 26010807 Review.
Cited by
- Neurological disease in xeroderma pigmentosum: prospective cohort study of its features and progression.
Garcia-Moreno H, Langbehn DR, Abiona A, Garrood I, Fleszar Z, Manes MA, Morley AMS, Craythorne E, Mohammed S, Henshaw T, Turner S, Naik H, Bodi I, Sarkany RPE, Fassihi H, Lehmann AR, Giunti P. Garcia-Moreno H, et al. Brain. 2023 Dec 1;146(12):5044-5059. doi: 10.1093/brain/awad266. Brain. 2023. PMID: 38040034 Free PMC article. - The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum.
Brooks PJ. Brooks PJ. Neuroscience. 2007 Apr 14;145(4):1407-17. doi: 10.1016/j.neuroscience.2006.10.025. Epub 2006 Dec 19. Neuroscience. 2007. PMID: 17184928 Free PMC article. Review. - Age-related neuronal degeneration: complementary roles of nucleotide excision repair and transcription-coupled repair in preventing neuropathology.
Jaarsma D, van der Pluijm I, de Waard MC, Haasdijk ED, Brandt R, Vermeij M, Rijksen Y, Maas A, van Steeg H, Hoeijmakers JH, van der Horst GT. Jaarsma D, et al. PLoS Genet. 2011 Dec;7(12):e1002405. doi: 10.1371/journal.pgen.1002405. Epub 2011 Dec 8. PLoS Genet. 2011. PMID: 22174697 Free PMC article. - The 8,5'-cyclopurine-2'-deoxynucleosides: candidate neurodegenerative DNA lesions in xeroderma pigmentosum, and unique probes of transcription and nucleotide excision repair.
Brooks PJ. Brooks PJ. DNA Repair (Amst). 2008 Jul 1;7(7):1168-79. doi: 10.1016/j.dnarep.2008.03.016. Epub 2008 May 20. DNA Repair (Amst). 2008. PMID: 18495558 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical